StonvexLoading…
StonvexStonvexStonvexCore line items from CDW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $6.25B | $5.68B | $22.42B | $16.91B | $11.18B |
Operating Income | Not available | $376.00M | $1.66B | $1.22B | $781.60M |
Net Income | Not available | $235.40M | $1.07B | $787.10M | $496.10M |
EPS (Diluted) | $2.80 | $1.82 | $8.08 | $5.94 | $3.73 |
Total Assets | Not available | $16.45B | $16.03B | $15.20B | $15.27B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $578.60M | $618.70M | $452.90M | $481.00M |
Free Cash Flow OCF − CapEx | Not available | $248.40M | $1.09B | $692.20M | $393.70M |
Shares Outstanding | Not available | 128.00M | 129.40M | 130.30M | 131.10M |